Skip to main content
Log in

Synergistic effect of MTHFR C677T and F2 G20210A polymorphisms on ischemic stroke

  • Original Article
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

Abstract

The predisposition to stroke might involve interactive effects among variants in several genes. We tested this hypothesis by examining the influence of polymorphisms in methylenetetrahydrofolate reductase (MTHFR) (C677T) and prothrombin (F2) (G20210A) as risk factors for stroke in Morocco. The polymerase chain reaction-restriction fragment length polymorphism methods were used to analyze DNA from 91 stroke patients and 182 controls. Association between the two polymorphisms and the risk of stroke was estimated by four-level models for the analysis of genetic interaction. Neither the MTHFR 677TT nor the F2 20210GA genotype showed any significant association compared to the MTHFR CC and F2 GG genotypes, respectively. An interactive effect between the MTHFR 677TT and F2 20210GA polymorphisms showed an increased risk of stroke. The odds ratios, in univariate and multivariate analysis, for the combined polymorphisms were 4.99 (95% CI, 1.75–14.2, P = 0.001) and 5.29 (95% CI, 1.63–17.1, P = 0.005), respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Flossman E, Schulz UGR, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004, 35: 212–227.

    Article  Google Scholar 

  2. Hassan A, Sham PC, Markus HS. Planning genetic studies in human stroke: sample size estimates based on family history data. Neurology 2002, 58: 1483–1488.

    Article  PubMed  Google Scholar 

  3. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain 2000, 123: 1784–1812.

    Article  PubMed  Google Scholar 

  4. Dichgans M. Genetics of ischemic stroke. Lancet Neurol 2000, 6: 149–161.

    Article  Google Scholar 

  5. Pezzini A, Grassi M, Del Zotto E, Archetti S, Spezi R, Vergani V, et al. Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke 2005, 36: 533–539.

    Article  PubMed  CAS  Google Scholar 

  6. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10: 111–113.

    Article  PubMed  CAS  Google Scholar 

  7. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996, 93: 7–9.

    Article  PubMed  CAS  Google Scholar 

  8. Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, et al. Factor V Leiden, prothrombin gene G20210A variant, and méthylènetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost 2001, 7: 346–350.

    Article  PubMed  CAS  Google Scholar 

  9. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, méthylènetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002, 33: 2351–2356.

    Article  PubMed  CAS  Google Scholar 

  10. They-They TP, Nadifi S, Rafai MA, Battas O, Slassi I. Methylenehydrofolate reductase (C677T) polymorphism and large artery ischemic stroke subtypes. Acta Neurol Scand 2011, 123: 105–110.

    Article  PubMed  CAS  Google Scholar 

  11. Casas JP, Hingorani AD, Bautista LE, Sharma P. Meta analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004, 61: 1652–1661.

    Article  PubMed  Google Scholar 

  12. Goracy I, CyryŁowski L, Kaczmarczyk M, Fabian A, Koziarska D, Goracy J, et al. C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects. J Appl Genet 2009, 50(1): 63–67.

    Article  PubMed  CAS  Google Scholar 

  13. Bentley P, Peck G, Smeeth L, Whittaker J, Sharma P. Causal relationship of susceptibility genes to ischemic stroke: Comparison to ischemic heart disease and biochemical determinants. PLoS One 2010, 5(2): e9136.

    Article  PubMed  Google Scholar 

  14. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88: 3698–3703.

    PubMed  CAS  Google Scholar 

  15. They-They TP, Battas O, Slassi I, Rafai MA, Katumbay DT, Nadifi S. Prothrombin G20210A and factor V Leiden polymorphisms in stroke. J Mol Neurosci 2012, 46(1): 210–216.

    Article  PubMed  CAS  Google Scholar 

  16. Szolnoki Z, Somogyvari F, Kondacs A, Szabó M, Fodor L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol 2002, 49: 1391–1397.

    Article  Google Scholar 

  17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988,16: 1215.

    Article  PubMed  CAS  Google Scholar 

  18. Danneberg J, Abbes AP, Bruggeman BJ, Engel H, Gerrits J, Martens A. Reliable genotyping of the G-20210A mutation of coagulation factor II (prothrombin). Clin Chem 1998, 44: 349–351.

    PubMed  CAS  Google Scholar 

  19. Voetsch B, Damasceno BP, Camargo EC, Massaro A, Bacheschi LA, Scaff M, et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000, 83: 229–233.

    PubMed  CAS  Google Scholar 

  20. Munshi A, Aliya N, Jyothy A, Kaul S, Alladi S, Shafi G. Prothombin gene G20210A mutation is not a risk factor for ischemic stroke in a South Indian Hyderabadi Population. Thromb Res 2009, 124: 245–247.

    Article  PubMed  CAS  Google Scholar 

  21. Xin XY, Song YY, Ma JF, Fan CN, Ding JQ, Yang GY, et al. Gene polymorphisms and risk of adult early-onset ischemic stroke: A meta-analysis. Thromb Res 2009, 124: 619–662.

    Article  PubMed  CAS  Google Scholar 

  22. Duca F, Sacchi E, Tagliabue L, Tajoli E. C677T méthylènetetrahydrofolate reductase (MTHFR) mutation in stroke. Thromb Haemost 1997, 78: 102.

    Google Scholar 

  23. Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P, Albertini A, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 2002, 33: 664–669.

    Article  PubMed  CAS  Google Scholar 

  24. Szolnoki Z, Somogyvári F, Kondacs A, Szabó M, Fodor L, Bene J, et al. Evaluation of the modifying effects of unfavorable genotypes on classical clinical risk factors for ischaemic stroke. J Neurol Neurosurg Psychiatry 2003, 74: 1615–1620.

    Article  PubMed  CAS  Google Scholar 

  25. De Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998, 91: 3562–3565.

    PubMed  Google Scholar 

  26. Aznar J, Mira Y, Vayá A, Corella D, Ferrando F, Villa P, et al. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost 2004, 91: 1031–1034.

    PubMed  CAS  Google Scholar 

  27. Botto N, Spadoni I, Giusti S, Ait-Ali L, Sicari R, Andreassi MG. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 2007, 38: 2070–2073.

    Article  PubMed  CAS  Google Scholar 

  28. Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, et al. Homocysteine, MTHFR 677C-T polymorphism, and risk of ischemic stroke: results of a metaanalysis. Neurology 2002, 59: 529–536.

    Article  PubMed  CAS  Google Scholar 

  29. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate redictase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 2003, 146: 948–957.

    Article  PubMed  CAS  Google Scholar 

  30. Stankovic S, Majkic-Singh N. Genetic aspects of ischemic stroke. Jugoslov Med Biohem 2005, 24: 225–239.

    Article  CAS  Google Scholar 

  31. Doggen CJ, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998, 97: 1037–1041.

    Article  PubMed  CAS  Google Scholar 

  32. Inbal A, Freimark D, Modan B, Chetrit A, Matetzky S, Rosenberg N, et al. Synergistic effects of prothrombotic Smokers polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood 1999, 39: 2186–2190.

    Google Scholar 

  33. Franco RF, Trip MD, ten Cate H, van den Ende A, Prins MH, Kastelein JJ, et al. the 20210 G→A mutation in the 3-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol 1999, 104: 50–54.

    Article  PubMed  CAS  Google Scholar 

  34. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a metaanalysis. BMJ 2002, 325: 1202.

    Article  PubMed  Google Scholar 

  35. Samman S, Sivarajah G, Man JC, Ahmad ZI, Petocz P, Caterson ID. A mixed fruit and vegetable concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J Nutr 2003, 133: 2188–2193.

    PubMed  CAS  Google Scholar 

  36. Biasi E. The effects of dietary choline. Neurosci Bull 2011, 27(5): 330–342.

    Article  PubMed  CAS  Google Scholar 

  37. Lalouel JM, Rohrwasser A. Power and replication in casecontrol studies. Am J Hypertens 2002, 15: 201–205.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thierry Paluku They-They.

Rights and permissions

Reprints and permissions

About this article

Cite this article

They-They, T.P., Battas, O. & Nadifi, S. Synergistic effect of MTHFR C677T and F2 G20210A polymorphisms on ischemic stroke. Neurosci. Bull. 29, 725–730 (2013). https://doi.org/10.1007/s12264-013-1381-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-013-1381-4

Keywords

Navigation